Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Applicaton of alpha interferon in external used medicine for treating eczema

A technology of interferon alpha and interferon, which is applied in the field of interferon alpha in the preparation of external medicines for treating eczema, can solve the problems of slow onset, side effects, and insignificant effects of skin cells, and achieves direct effect, mild medicinal properties, and poor resolution. Effects of reaction to sleepiness

Active Publication Date: 2005-01-05
ZHAOKE PHARMA HEFEI
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0017] At present, domestic and foreign studies mostly use interferon for systemic treatment, which has the disadvantage of not having obvious effects on skin cells
It is well known that systemic interferon treatment of local skin diseases is not only slow onset, but also accompanied by systemic side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1 Preparation of alpha interferon ointment

[0036] Using the conventional ointment preparation process, α-2a interferon ointment and α-2b interferon ointment were prepared respectively, the concentration of which was 5×10 4 IU / ml.

Embodiment 2

[0037] Example 2 Preparation of alpha interferon emulsion

[0038] Using the conventional emulsion preparation process, α-2a interferon emulsion and α-2b interferon emulsion were prepared respectively, and the concentrations were 5×10 5 IU / ml.

Embodiment 3

[0039] Example 3 Preparation of alpha interferon solution

[0040] Using a conventional solution preparation process, α-2a interferon solution and α-2b interferon solution were prepared respectively, the concentration of which was 5×10 6 IU / ml.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An application of alpha-2a interferon and alpha-2b interferon in preparing the external-application medicine for treating eczema is disclosed.

Description

technical field [0001] The invention relates to the application of alpha interferon in the preparation of external medicine for treating eczema, especially the application of alpha-2a interferon and alpha-2b interferon in the preparation of external medicine for treating eczema. Background technique [0002] Eczema (Eczema-Dermatitis) is a skin inflammatory reaction with pleomorphic skin lesions and a tendency to exudate caused by a variety of complex internal and external factors. The subjective symptoms are severe itching, the state of an illness is easy to repeat, and can not heal for many years. It is often a delayed-type allergic reaction caused by the interaction of various internal and external factors. The onset is related to the body's allergic quality, neuropsychiatric factors, and allergic reactions. [0003] The clinical manifestations of eczema are: [0004] (1) Acute eczema: It can occur in any part of the body, and it is common in the head, face, behind the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K9/08A61K9/107A61K9/12A61K38/21A61P17/00
Inventor 李兆羿张国辉杨中强
Owner ZHAOKE PHARMA HEFEI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com